Objective: To determine the correlation of non-invasive tests with conventional tear function tests in dry eye patients. Material and Methods: One hundred and twenty-two eyes of 61 patients over 18 years old who applied to Çanakkale Onsekiz Mart University School of Medicine, Department of Ophthalmology with dry eye were included in the study. After general ophthalmological examination including best corrected visual acuity, biomicroscopic examination, non-invasive methods like Ocular Surface Disease Index (OSDI) scoring, tear osmolarity, non-invasive tear break-up time (NI-TBUT) measurement with Scheimpflug topography, meibomography, and measurement of the lower lid meniscus height (TMH) with optical coherence tomography were performed. After non-invasive tests, conventional tear function tests like Schirmer test, TBUT, cornea and conjunctiva staining were applied respectively. Results: A positive correlation was found between NI-TBUT and conventional TBUT (p<0.01 Spearman's rho: 0.473). TBUT was found to be positively correlated with Schirmer test and negatively correlated with corneoconjunctival staining (p<0.01 Spearman's rho: 0.393, rho:-0.418). Schirmer test results were correlated positively with TMH and negatively correlated with OSDI scoring and corneoconjunctival staining (p<0.05 Spearman's rho: 0.181; p<0.05 Spearman's rho:-0.214; p<0.01 Spearman's rho:- 0.394). Tear osmolarity test results and meibomography did not correlate with any test. Conclusion: The non-invasive and objective measurement of NI-TBUT may be a better diagnostic modality than TBUT for dry eye patients. Tear osmolarity and meibomography were not significant for diagnosis of early stage dry eye patients.
Keywords: Kuru göz sendromu; ozmolar konsantrasyon; Schirmer testi; gözyaşı menisküs yüksekliği; gözyaşı ozmolaritesi; gözyaşı kırılma zamanı; meibomografi
Amaç: Kuru göz hastalarında, noninvaziv testlerin, konvansiyonel gözyaşı fonksiyon testleri ile korelasyonunu araştırmak. Gereç ve Yöntemler: Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalına başvuran ve kuru gözü olan 18 yaşından büyük 61 hastanın 122 gözü çalışmaya alındı. Hastalara en iyi düzeltilmiş görme keskinliği ölçümü, biyomikroskobik ve oftalmoskopik muayeneyi içeren genel oftalmolojik muayene sonrasında sırasıyla noninvaziv yöntemler olan, 'Ocular Surface Disease Index (OSDI)' anketi, gözyaşı ozmolaritesi ölçümü, Scheimpflug topografi ile noninvaziv gözyaşı kırılma zamanı (Nİ-GKZ), meibomografi ve optik koherens tomografi ile alt kapak gözyaşı menisküs yüksekliği (GMY) ölçüldü. Noninvaziv yöntemler sonrasında sırasıyla geleneksel gözyaşı fonksiyon testleri olan Schirmer testi, GKZ, kornea ve konjonktivanın boyanması yapıldı. Bulgular: Nİ-GKZ ile GKZ arasında pozitif korelasyon saptandı (p<0,01 Spearman'ın rho: 0,473). GKZ'nin Schirmer testi ile pozitif, korneal boyanma ile negatif korelasyonu olduğu saptandı (p<0,01 Spearman'ın rho: 0,393; rho: -0,418). Schirmer testi, GMY ile pozitif, OSDI skoru ve korneokonjonktival boyanma ile negatif korele idi (p<0,05 Spearman'ın rho: 0,181; p<0,05 Spearman'ın rho: -0,214; p<0,01 Spearman'ın rho: -0,394). Gözyaşı ozmolaritesi ve meibomografi testlerinin hiçbir testle korelasyon göstermediği tespit edildi. Sonuç: Nİ-GKZ, noninvaziv ve objektif bir ölçüm olması sebebiyle, kuru göz hastalarında GKZ'den daha iyi bir tanısal yöntem olabilir. Gözyaşı ozmolaritesi ölçümü ve meibomografi sonuçları özellikle erken evre kuru gözhastalarının tanısında anlamlı bulunmamıştır.
Anahtar Kelimeler: Dry eye syndrome; osmolar concentration; Schirmer test; tear meniscus height; tear osmolarity; tear break-up time; meibomography
- Nelson JD, Craig JP, Akpek EK, Azar DT, Belmonte C, Bron AJ, et al. TFOS DEWS II Introduction. Ocul Surf. 2017;15(3):269-75.[Crossref] [PubMed]
- The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):75-92.[Crossref] [PubMed]
- Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264-8.[Crossref] [PubMed]
- Lee AJ, Lee J, Saw SM, Gazzard G, Koh D, Widjaja D, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86(12):1347-51.[Crossref] [PubMed] [PMC]
- Versura P, Cellini M, Torreggiani A, Profazio V, Bernabini B, Caramazza R. Dryness symptoms, diagnostic protocol and therapeutic management: a report on 1,200 patients. Ophthalmic Res. 2001;33(4):221-7.[Crossref] [PubMed]
- Bayhan HA, Gürdal C, Takmaz T, Can İ. [Comparison of lissamine green and rose bengal in dry eye diagnosis and correlation between patient symptoms and clinical tests]. Turk J Ophthalmol 2010;40(1):29-33.[Link]
- Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161-6.[Crossref] [PubMed]
- Taşkıran Çömez A, Kömür B, Şanal E, Tufan HA. [The relationship between tear osmolarity, Ocular Surface Disease Index© and other tear function tests]. Turkiye Klinikleri J Med Sci. 2013;33(2):455-63.[Crossref]
- Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151(5):792-8.[Crossref] [PubMed]
- Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615-21.[Crossref] [PubMed]
- Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(12):6125-30.[Crossref] [PubMed]
- Fuentes-Páez G, Herreras JM, Cordero Y, Almaraz A, González MJ, Calonge M. [Lack of concordance between dry eye syndrome questionnaires and diagnostic tests]. Arch Soc Esp Oftalmol. 2011;86(1):3-7.[Crossref] [PubMed]
- Karalezli A, Borazan M, Küçükerdönmez C, Akova YA. [Comparison of the effect of different concentrations of topical sodium hyaluronate eye drops for the treatment of dry eye]. Turkiye Klinikleri J Ophthalmol. 2010;19(2):78-83.[Link]
- Tuisku IS, Konttinen YT, Konttinen LM, Tervo TM. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res. 2008;86(6):879-85.[Crossref] [PubMed]
- Schmidl D, Witkowska KJ, Kaya S, Baar C, Faatz H, Nepp J, et al. The association between subjective and objective parameters for the assessment of dry-eye syndrome. Invest Ophthalmol Vis Sci. 2015;56(3):1467-72.[Crossref] [PubMed]
- Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea. 2011;30(12):1289-92.[Crossref] [PubMed]
- Potvin R, Makari S, Rapuano CJ. Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol. 2015;9:2039-47.[Crossref] [PubMed] [PMC]
- Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol. 2010;45:129-38.[Crossref] [PubMed]
- Szalai E, Berta A, Szekanecz Z, Szûcs G, Módis L Jr. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea. 2012;31(8):867-71.[Crossref] [PubMed]
- Sullivan BD, Crews LA, Sönmez B, de la Paz MF, Comert E, Charoenrook V, et al. Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea. 2012;31(9):1000-8.[Crossref] [PubMed]
- Walsh NP, Fortes MB, Raymond-Barker P, Bishop C, Owen J, Tye E, et al. Is whole-body hydration an important consideration in dry eye? Invest Ophthalmol Vis Sci. 2012;53(10):6622-7.[Crossref] [PubMed]
- Bunya VY, Langelier N, Chen S, Pistilli M, Vivino FB, Massaro-Giordano G. Tear osmolarity in Sjögren syndrome. Cornea. 2013;32(7):922-7.[Crossref] [PubMed] [PMC]
- Di Tommaso C, Valamanesh F, Miller F, Furrer P, Rodriguez-Aller M, Behar-Cohen F, et al. A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation. Invest Ophthalmol Vis Sci. 2012;53(4):2292-9.[Crossref] [PubMed]
- Cho KJ, Mok JW, Choi MY, Kim JY, Joo CK. Changes in corneal sensation and ocular surface in patients with asymmetrical keratoconus. Cornea. 2013;32(2):205-10.[Crossref] [PubMed]
- Yang Y, Abrams M, Garner W, Rinehart M, Senic BP, Shimada H, et al. An exploration of the relationships between tear osmolarity and other measures of dry eye signs and symptoms. Invest Ophthalmol Vis Sci. 2012;53:548.[Link]
- Kim M, Kim HS, Na KS. Correlation between tear osmolarity and other ocular surface parameters in primary Sjögren's syndrome. Korean J Ophthalmol. 2017;31(1):25-31.[Crossref] [PubMed] [PMC]
- Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol. 1996;122(6):818-24.[Crossref] [PubMed]
- Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in singapore. Invest Ophthalmol Vis Sci. 2010;51(7):3449-54.[Crossref] [PubMed]
- Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, et al; Asia Dry Eye Society. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society. Ocul Surf. 2017;15(1):65-76.[PubMed]
- Lamble JW, Gilbert D, Ashford JJ. The break-up time of artificial pre-ocular films on the rabbit cornea. J Pharm Pharmacol. 1976;28(5):450-1.[Crossref] [PubMed]
- Gumus K, Crockett CH, Rao K, Yeu E, Weikert MP, Shirayama M, et al. Noninvasive assessment of tear stability with the tear stability analysis system in tear dysfunction patients. Invest Ophthalmol Vis Sci. 2011;52(1):456-61.[Crossref] [PubMed] [PMC]
- Best N, Drury L, Wolffsohn JS. Clinical evaluation of the Oculus Keratograph. Cont Lens Anterior Eye. 2012;35(4):171-4.[Crossref] [PubMed]
- Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762-70.[Crossref] [PubMed]
- Savini G, Barboni P, Zanini M. Tear meniscus evaluation by optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2006;37(2):112-8.[Crossref] [PubMed]
- Czajkowski G, Kaluzny BJ, Laudencka A, Malukiewicz G, Kaluzny JJ. Tear meniscus measurement by spectral optical coherence tomography. Optom Vis Sci. 2012;89(3):336-42.[Crossref] [PubMed]
- Oguz H, Yokoi N, Kinoshita S. The height and radius of the tear meniscus and methods for examining these parameters. Cornea. 2000;19(4):497-500.[Crossref] [PubMed]
- Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006-49.[Crossref] [PubMed] [PMC]
- Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1982;22(5):660-7.[PubMed]
- Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Fukuoka S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009;116(11):2058-63.[Crossref] [PubMed]
- Gupta PK, Stevens MN, Kashyap N, Priestley Y. Prevalence of meibomian gland atrophy in a pediatric population. Cornea. 2018;37(4):426-30.[Crossref] [PubMed] [PMC]
- Meadows JF, Ramamoorthy P, Nichols JJ, Nichols KK. Development of the 4-3-2-1 meibum expressibility scale. Eye Contact Lens. 2012;38(2):86-92.[Crossref] [PubMed]
.: Process List